Published in Mov Disord on June 15, 2013
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience (2013) 1.20
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. Am J Hum Genet (2015) 0.93
Clinical, Etiological, and Therapeutic Features of Jaw-opening and Jaw-closing Oromandibular Dystonias: A Decade of Experience at a Single Treatment Center. Tremor Other Hyperkinet Mov (N Y) (2014) 0.91
Diagnosis and treatment of dystonia. Neurol Clin (2015) 0.90
Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia. Neurobiol Dis (2013) 0.84
Designing clinical trials for dystonia. Neurotherapeutics (2014) 0.82
The New Classification System for the Dystonias: Why Was it Needed and How was it Developed? Mov Disord Clin Pract (2014) 0.80
Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing. J Neural Transm (Vienna) (2017) 0.79
Dystonia and cerebellar degeneration in the leaner mouse mutant. Brain Res (2015) 0.79
Microfluidic platform to evaluate migration of cells from patients with DYT1 dystonia. J Neurosci Methods (2014) 0.78
How Many Dystonias? Clinical Evidence. Front Neurol (2017) 0.75
The dystonias: past, present, and future. Mov Disord (2013) 0.75
Clinical Management of Dystonia in Childhood. Paediatr Drugs (2017) 0.75
Evolving concepts in the pathogenesis of dystonia. Parkinsonism Relat Disord (2017) 0.75
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med (2003) 6.47
Wilson's disease. Lancet (2007) 5.90
Phenomenology and classification of dystonia: a consensus update. Mov Disord (2013) 4.98
Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry (1980) 3.19
Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain (2011) 2.80
Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet (2011) 2.48
Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol (2011) 2.30
Delineation of the motor disorder of Lesch-Nyhan disease. Brain (2006) 2.30
Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol (1977) 2.29
Paroxysmal dyskinesias: clinical features and classification. Ann Neurol (1995) 2.21
The functional neuroanatomy of dystonia. Neurobiol Dis (2011) 2.08
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Essential myoclonus and myoclonic dystonia. Mov Disord (1996) 1.76
Biotin-responsive basal ganglia disease: a novel entity. Brain (1998) 1.74
Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology (2006) 1.72
Movement disorders in spinocerebellar ataxias. Mov Disord (2011) 1.72
MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol (2006) 1.62
Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study. Dev Med Child Neurol (2012) 1.61
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest (2008) 1.60
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord (2010) 1.56
Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov Disord (2010) 1.54
Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology (2012) 1.48
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
Diagnostic approach in patients with symmetric imaging lesions of the deep gray nuclei. Neurologist (2003) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Neurological manifestations in Wilson's disease: Report of 119 cases. Mov Disord (2006) 1.35
Myoclonic dystonia. Neurology (1983) 1.34
The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol (2011) 1.30
Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol (1988) 1.30
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet (2004) 1.29
Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol (2003) 1.27
Syndromes of neurodegeneration with brain iron accumulation. Semin Pediatr Neurol (2012) 1.22
The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat Disord (2008) 1.22
The motor phenotype of Parkinson's disease in relation to age at onset. Mov Disord (2011) 1.20
Adult-onset primary lower limb dystonia. Mov Disord (2006) 1.20
A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet (1995) 1.18
Tremor and idiopathic dystonia. Mov Disord (1991) 1.18
Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology (2012) 1.17
Secondary paroxysmal dyskinesias. Mov Disord (2002) 1.17
Dystonia: the spectrum of the disease. Res Publ Assoc Res Nerv Ment Dis (1976) 1.14
Pallido-pyramidal disease. J Neuropathol Exp Neurol (1954) 1.13
Secondary dystonia. Adv Neurol (1988) 1.07
Investigation of dystonia. Adv Neurol (1988) 1.05
The syndrome of deafness-dystonia: clinical and genetic heterogeneity. Mov Disord (2013) 1.01
Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1. Am J Med Genet A (2007) 1.00
Inherited myoclonus-dystonia syndrome. Adv Neurol (1998) 1.00
Dystonia in the Woodhouse Sakati syndrome: A new family and literature review. Mov Disord (2008) 0.93
The clinical approach to movement disorders. Nat Rev Neurol (2010) 0.92
Markedly severe dystonia in Japanese encephalitis. Mov Disord (2000) 0.92
The lumbar puncture for diagnosis of pediatric neurotransmitter diseases. Ann Neurol (2003) 0.91
Focal dystonia as a presenting sign of spinocerebellar ataxia 17. Mov Disord (2004) 0.90
Late onset Wilson's disease: therapeutic implications. Mov Disord (2008) 0.89
Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord (2010) 0.87
Athetosis II: the syndrome of mild athetoid cerebral palsy. Mov Disord (2002) 0.86
The definition of dystonia: current concepts and controversies. Mov Disord (2013) 0.85
Dystonia in spinocerebellar ataxia type 6. Mov Disord (2002) 0.85
Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Arch Neurol (2012) 0.85
Athetosis I: historical considerations. Mov Disord (2002) 0.84
Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis (2008) 0.84
A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Ann Neurol (2001) 0.83
Ataxia with vitamin E deficiency and severe dystonia: report of a case. Brain Dev (2003) 0.83
The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease. QJM (2011) 0.81
Secondary dystonia--clinical clues and syndromic associations. Eur J Neurol (2010) 0.81
Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology (2012) 0.80
Early Controversies over Athetosis: I. Clinical Features, Differentiation from other Movement Disorders, Associated Conditions, and Pathology. Tremor Other Hyperkinet Mov (N Y) (2013) 0.79
The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome. Mov Disord (2012) 0.77
The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism. J Inherit Metab Dis (2008) 0.77
To test or not? The value of diagnostic tests in cervical dystonia. Mov Disord (2001) 0.77
Pallidopyramidal disease: a misnomer? Mov Disord (2010) 0.76
Patient with late-onset Wilson's disease: deterioration with penicillamine. Mov Disord (2007) 0.76
Phenomenology and classification of dystonia: a consensus update. Mov Disord (2013) 4.98
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet (1999) 4.06
Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol (2008) 3.00
β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40
The syndrome of fixed dystonia: an evaluation of 103 patients. Brain (2004) 2.36
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet (2010) 2.21
Environmental neurotoxin-induced progressive model of parkinsonism in rats. Ann Neurol (2010) 2.17
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med (2009) 2.09
The functional neuroanatomy of dystonia. Neurobiol Dis (2011) 2.08
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. Neurology (2013) 2.06
Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord (2011) 2.02
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry (2012) 1.94
Myoclonus-dystonia: an update. Mov Disord (2009) 1.90
The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain (2008) 1.82
Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to ε-sarcoglycan mutations: a pilot study. Arch Neurol (2011) 1.79
Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol (2007) 1.72
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain (2008) 1.72
Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev (2000) 1.71
Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome. Brain (2012) 1.69
Neuropathology of cervical dystonia. Exp Neurol (2012) 1.69
Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain (2003) 1.68
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet (2010) 1.67
Abnormal cerebellar signaling induces dystonia in mice. J Neurosci (2002) 1.67
Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity. Mov Disord (2012) 1.64
A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol (2006) 1.61
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol (2012) 1.61
Patient-based outcomes of cervical dystonia: a review of rating scales. Mov Disord (2004) 1.59
Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study. Lancet Neurol (2013) 1.55
Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch Neurol (2002) 1.54
Restoration of normal motor control in Parkinson's disease during REM sleep. Brain (2007) 1.47
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain (2009) 1.44
How much phenotypic variation can be attributed to parkin genotype? Ann Neurol (2003) 1.44
Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease. Mov Disord (2007) 1.42
TENS for the treatment of propriospinal myoclonus. Mov Disord (2008) 1.41
Serum uric acid and brain ischemia in normal elderly adults. Neurology (2007) 1.39
FXTAS: new insights and the need for revised diagnostic criteria. Neurology (2012) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum? Neurology (2006) 1.37
Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology (2007) 1.33
Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
Behavioral aspects of Lesch-Nyhan disease and its variants. Dev Med Child Neurol (2005) 1.29
The anatomical basis of dystonia: current view using neuroimaging. Mov Disord (2013) 1.27
REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep (2005) 1.22
Dystonia rating scales: critique and recommendations. Mov Disord (2013) 1.17
Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain (2013) 1.17
Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants. Curr Rheumatol Rep (2012) 1.16
Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. J Int Neuropsychol Soc (2001) 1.15
HPRT deficiency coordinately dysregulates canonical Wnt and presenilin-1 signaling: a neuro-developmental regulatory role for a housekeeping gene? PLoS One (2011) 1.15
Extreme task specificity in writer's cramp. Mov Disord (2011) 1.15
Consequences of impaired purine recycling in dopaminergic neurons. Neuroscience (2008) 1.14
Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis (2012) 1.12
Screening for VPS35 mutations in Parkinson's disease. Neurobiol Aging (2011) 1.12
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease. Ann Neurol (2004) 1.11
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord (2005) 1.09
Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain (2010) 1.09
Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis. Hum Mol Genet (2009) 1.07
Defective cerebellar control of cortical plasticity in writer's cramp. Brain (2013) 1.06
Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol Dis (2007) 1.06
Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study. Brain (2004) 1.06
Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol Biochem Behav (2002) 1.06
Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord (2006) 1.06
RAD51 deficiency disrupts the corticospinal lateralization of motor control. Brain (2013) 1.06
[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. Ann Neurol (2003) 1.05
Normal and pathological gait: what we learn from Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.04
Animal models of generalized dystonia. NeuroRx (2005) 1.04
RAD51 haploinsufficiency causes congenital mirror movements in humans. Am J Hum Genet (2012) 1.04
[123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism. J Neurol Sci (2008) 1.04
Selective and sustained α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice. J Pharmacol Exp Ther (2011) 1.04
Abnormal motor behavior and vestibular dysfunction in the stargazer mouse mutant. Neuroscience (2004) 1.03
Self-injurious behavior: gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev (2001) 1.03
Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum (2009) 1.02
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain (2013) 1.02
A human neuronal tissue culture model for Lesch-Nyhan disease. J Neurochem (2007) 1.01
Sleep fragmentation and motor restlessness in a Drosophila model of Restless Legs Syndrome. Curr Biol (2012) 1.01
PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology (2012) 0.99
Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J Neurosci (1992) 0.99
Micrographia secondary to lenticular lesions. Mov Disord (2002) 0.99
Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis. Mov Disord (2012) 0.99
Paroxysmal dyskinesias in mice. Mov Disord (2008) 0.99
Motor execution and imagination networks in post-stroke dystonia. Neuroreport (2004) 0.99
Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson's disease. Brain Cogn (2005) 0.98
Keeping your head on target. J Neurosci (2013) 0.98
Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Disord (2007) 0.98
Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? PLoS One (2010) 0.98
Irregularity distinguishes limb tremor in cervical dystonia from essential tremor. J Neurol Neurosurg Psychiatry (2007) 0.98
Tremor in inflammatory neuropathies. J Neurol Neurosurg Psychiatry (2012) 0.97
Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis (2012) 0.97
Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol (2008) 0.97
LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. Arch Neurol (2007) 0.97
Altered dorsal premotor-motor interhemispheric pathway activity in focal arm dystonia. Mov Disord (2008) 0.96
EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants? Neurobiol Aging (2012) 0.96
Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clin Cancer Res (2013) 0.96